Please provide your email address to receive an email when new articles are posted on . Best corrected visual acuity was the only visual function test ready for use in a diabetic retinal disease ...
The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...
Scientists at EPFL have developed an innovative, non-invasive brain stimulation therapy to significantly improve visual function in stroke patients who have suffered vision loss following a stroke.
SYFOVRE is the only approved GA treatment to demonstrate a visual function benefit in a prespecified endpoint Data presented at the Clinical Trials at the Summit Meeting In a prespecified ...
Share on Pinterest New research involving cones and rods in the retina could lead to new treatments for vision loss. Gregory Adams/Getty Images Cone photoreceptors in retinal degeneration have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results